Join
Shorts
Not every wealthy person has a Forbes profile. Not every successful investor trends on Twitter. Some of the most financially savvy people in America quietly build empires while the world looks the other way.
Matthew Schissler is one of those people.
When people search for Matthew Schissler net worth, they expect a clean, flashy number. What they find instead is something far more interesting – a trail of SEC filings, bold biotech bets, international acquisitions, private investment funds, and a philosophy of wealth that puts contribution above cash.
So, what is Matthew Schissler’s net worth in 2026? How did he build his financial standing? And why is his story worth knowing?
Let’s break it all down.
Matthew Schissler Net Worth 2026: What We Know
Estimated Net Worth: $5 Million – $20 Million (Privately Held)
Here’s the truth: Matthew Schissler‘s exact net worth is not publicly confirmed by major wealth trackers like Forbes or Bloomberg. Unlike celebrity CEOs, Schissler operates almost entirely through private equity vehicles and insider ownership – making a precise figure impossible to pin down without full financial disclosure.
What is available comes from SEC filings, public company records, and his known business portfolio.
His wealth trajectory has grown steadily since 2003, but unlike many public figures, the growth isn’t measured in headlines — it’s measured in equity stakes, long-term fund performance, and board-level influence.
Early Life & Background From the Classroom to the Boardroom
Matthew Schissler was born on June 9, 1971, in the United States. He grew up with an interest in science and public policy — a combination that would later prove to be his secret weapon in the world of biotech entrepreneurship.
He attended St. Mary’s College of Maryland, where he earned a degree in Biology and Public Policy in 1993. That unusual blend of hard science and governance thinking laid the groundwork for everything that followed.
While most of his classmates went into traditional scientific or academic careers, Schissler took a different path – one that would eventually lead him to build one of America’s most recognised cord blood banking companies.
His early career details are not widely documented, but by the early 2000s, he had clearly developed a sharp eye for market opportunities that others hadn’t yet spotted.
Career Journey: Building Wealth Through Vision
Spotting Opportunity Before the Crowd
Matthew Schissler’s professional story is defined by one recurring trait: he was always early.
Early to recognize a market. Early to act. Early to move when others hesitated.
That instinct drove him into the biotech sector at a time when the concept of cord blood banking was still foreign to most families. Rather than joining an existing company, he decided to build his own.
👉 Read Also:
- Apostle Kathryn Krick Biography: Age, Ministry, Net Worth & 5F Church (2026)
- Cody Jinks Biography 2026: From Fort Worth Metal Vocalist to Outlaw Country’s Most Independent Star
- Pastor Ken Graves Biography 2026: From Maine’s Poorest Kid to Calvary Chapel Bangor Founder
- Lourenco Goncalves Biography 2026: From Brazilian Steel Mills to Chairman & CEO of Cleveland-Cliffs Inc.
Major Career Milestones
Business Ventures & Companies
The Portfolio That Built Matthew Schissler’s Earnings
Understanding Matthew Schissler’s business ventures is the key to understanding his net worth. He has never been a salary-driven executive. His wealth is tied to equity ownership and strategic positioning in companies he believes in.
1. Cord Blood America, Inc. (CBAI) – The Flagship
In 2003, Schissler founded Cord Blood America with a simple but powerful idea: families should have access to stored umbilical cord blood for potential future medical use.
At a time when most people had never heard of cord blood banking, he saw the future clearly. Under his leadership as Chairman of the Board and CEO, CBAI:
- Acquired CorCell Inc. — the 4th largest cord blood bank in America at the time
- Acquired CureSource, a Charleston-based storage facility
- Expanded into Germany by acquiring 51% of stellacure GmbH
- Entered South America through majority ownership of BioCells Argentina
- Founded China Stem Cells, Inc. for operations in northeast China
- Acquired Reproductive Genetics Institute, Inc. and NeoCells (both Chicago-based)
By the time he stepped away in 2012, Cord Blood America had become a truly international biotech enterprise. This decade-long run significantly contributed to Matthew Schissler’s earnings and equity base.
2. Work Your Core Investments (WYC), LLC
Founded in 2021, Work Your Core Investments is a privately held fund focused on fitness franchises and performance-driven business models. Schissler serves as its Founder and Managing Member.
The fund targets unique fitness concepts with high growth potential – a sector that has seen tremendous post-pandemic expansion. This positions WYC as a strong long-term income source within Schissler’s portfolio.3. Private Investment Funds (Multiple)
Since 2015, Schissler has managed a series of private “super value” funds focused on small to mid-cap public companies. These are the invisible engines of his wealth.
His investment strategy focuses on:
- Companies with strong fundamentals often overlooked by mainstream investors
- Long-term value creation over short-term gains
- Leadership teams committed to sustainable growth
- Real returns driven by real business performance — not hype
4. IIOT-OXYS Inc. (ITOX)
Schissler currently serves as a Director on the board of IIOT-OXYS Inc., a publicly traded technology company (ticker: ITOX). SEC filings from GuruFocus confirm his insider ownership status. While his exact equity stake is small, the role reflects his ongoing commitment to board-level influence in growth companies.
5. Aztec Airways
In 2021, Schissler joined the Board of Directors of Aztec Airways, a Fort Lauderdale-based aviation company. This move into aviation underscores his diversification strategy and appetite for emerging transport sector opportunities.
Income Sources Breakdown
How Does Matthew Schissler Make Money?
His income doesn’t come from a single paycheck. It flows from multiple streams – a deliberate strategy for financial resilience.
| Income Source | Description |
|---|---|
| Private Investment Returns | Returns from his “super value” private funds (small/mid-cap companies) |
| Equity Ownership | Insider equity stakes in public companies (IIOT-OXYS etc.) |
| Work Your Core Investments | Returns from fitness franchise investments |
| Board Director Fees | Compensation for board roles (Aztec Airways, IIOT-OXYS) |
| Strategic Advisory Fees | Consulting & advisory for growing businesses |
| Business Leadership | Historical earnings from CBAI (2003–2012) |
The largest contributor to Matthew Schissler’s income is almost certainly his private investment fund activity, given his track record of two decades in equity-focused investing.
Assets & Lifestyle How He Lives
Matthew Schissler maintains a notably low public profile for someone with his business track record. He is based in the Las Vegas, Nevada and Paradise Valley, Arizona areas — both tax-efficient locations favored by high-net-worth individuals.
His known assets and lifestyle indicators include:
While he doesn’t flash luxury publicly, his investment-driven wealth suggests significant underlying assets.
Achievements & Recognition
A Career Full of Quiet Wins
Matthew Schissler has never chased awards. But they’ve found him anyway.
- 🏆 2008 — Finalist, Ernst & Young Entrepreneur of the Year Award
- 🧬 2011 — Named Chairman, Biotech Committee, Nevada Development Authority
- 🎓 Board of Advisors, Las Vegas Science Festival
- 🦕 Board of Directors, Las Vegas Natural History Museum
- 🌍 Built an international biotech company spanning USA, Germany, Argentina, and China
- 📊 Recognized as a credible SEC-registered insider investor in small-cap public markets
Personal Life The Man Behind the Business
Matthew Schissler keeps his personal life mostly private. What is publicly known:
Those who’ve worked with him describe Schissler as someone who leads with integrity, thinks long-term, and genuinely invests in the people around him – not just the companies.
His own words reflect this: “Value is what you leave behind when you walk away. Did you make something stronger? Did you help someone move forward? That’s what matters.”
Lesser-Known Facts About Matthew Schissler
Here are 7 things most people don’t know about this private investor and entrepreneur:
Future Growth & Net Worth Prediction
Where Is Matthew Schissler Headed?
Based on his current trajectory, Matthew Schissler’s financial future looks strong for several reasons:
If his private funds continue performing and his fitness and aviation investments mature, a substantial net worth increase is well within reach.
Conclusion: The Real Measure of Matthew Schissler’s Worth
Matthew Schissler‘s story isn’t a typical rags-to-riches tale. It’s something more nuanced – and arguably more inspiring.
He built an international biotech company from scratch. He quietly assembled a portfolio of private investment funds. He joined boards, mentored leaders, and shaped industries – all without ever chasing a headline.
The question of Matthew Schissler’s net worth may not have a clean, Google-ready answer. But the real value of his career is written in the companies he built, the jobs he created, and the investment philosophy he represents.
In his own words: “You won’t always control the outcome. But you control how you show up. If you keep showing up with integrity, you’ll build something that lasts. And that’s worth more than anything you can measure.“
That’s a lesson worth far more than any net worth figure.
Frequently Asked Questions – Matthew Schissler
What is Matthew Schissler’s net worth in 2026?
Matthew Schissler’s exact net worth in 2026 is not publicly confirmed by major financial trackers. Based on his known business ventures, private investment funds, equity ownership, and career history, analysts estimate his net worth to be in the range of $5 million to $20 million, though actual figures could be higher given his private holdings.
How does Matthew Schissler make money?
Matthew Schissler generates income through multiple streams: returns from his private investment funds focused on small and mid-cap companies, equity ownership in public companies like IIOT-OXYS Inc., board director fees (Aztec Airways, IIOT-OXYS), strategic advisory services, and returns from Work Your Core Investments – his fitness franchise fund.
What companies is Matthew Schissler associated with?
He is associated with: Cord Blood America, Inc. (CBAI) (founder and former CEO), Work Your Core Investments (WYC), LLC (founder and managing member), IIOT-OXYS Inc. (ITOX) (board director), Aztec Airways (board director), China Stem Cells, Inc. (founder), and GHS (33% owner per SEC filings).
Is Matthew Schissler a millionaire or billionaire?
Based on available public information, Matthew Schissler is most likely a multi-millionaire, with an estimated wealth in the $5M – $20M range. There is no confirmed evidence placing him in billionaire territory, though his private holdings are not fully disclosed.
What is Matthew Schissler’s main source of income?
His primary income source is believed to be his private investment fund activities — specifically the “super value” funds he has managed since 2015, focused on small and mid-cap public companies. Historical income from building and running Cord Blood America for nearly a decade also formed a major part of his earnings base
What is Matthew Schissler’s educational background?
He holds a degree in Biology and Public Policy from St. Mary’s College of Maryland, where he graduated in 1993. This dual focus on science and governance proved foundational to his career in biotech and corporate leadership.
Where does Matthew Schissler live?
As of 2026, Matthew Schissler is based in Las Vegas, Nevada and Paradise Valley, Arizona — both known for business-friendly tax environments favored by high-net-worth individuals and investors
Sources & References
Last Updated: April 16, 2026
Disclaimer: The net worth figures mentioned in this article are based on publicly available information, SEC filings, and analyst estimates. They are not officially confirmed by Matthew Schissler or any financial authority. This article is for informational purposes only.
